News Archive
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) announced the selection of Hematology and Oncology Fellows, Walaa Aldhahri, MBBS, and Zoë McKinnell, MD, as the 2023 Albert L. Tucker and Elizabeth T. Tucker Postdoctoral Fellowship awardees.
The George Washington University School of Medicine and Health Sciences faculty promotion and/or tenure list and the members of the Class of 2023 Emeriti Faculty.
The George Washington University (GW) School of Medicine and Health Sciences Physical Therapy honors the Class of 2023 at annual awards ceremony.
The George Washington University (GW) School of Medicine and Health Sciences Physician Assistant Studies Program hosts annual awards program for the Class of 2023.
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) Department of Obstetrics and Gynecology hosted the 86th annual Kane King Dodek Obstetrical Honor Society annual awards ceremony.
The George Washington University School of Medicine and Health Sciences celebrated the achievement of the Health Sciences Program Class of 2023, 391 members strong, representing 27 disciplines offered by GW.
The George Washington University MD Program Class of 2023 celebrates annual hooding and diploma ceremony featuring an address by Edward Barksdale Jr., MD, the Robert J. Izant Jr., MD, Professor and Surgeon-in-Chief at Rainbow Babies and Children’s Hospital/University Hospitals and Case Western…
The George Washington University School of Medicine and Health Sciences welcomed the newest members of the Alpha Chapter of the Alpha Omega Alpha Medical Honor Society, and hosted Carolyn Sufrin, MD, PhD, as the 15th Annual AΩA Visiting Professor.
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) is pleased to announce that Stephanie Sarandos, MA, has been selected to serve as the assistant dean for evaluation. In this role, Sarandos will be responsible for all aspects of MD program evaluation, ensuring…
Pfizer has launched a Phase 3 study of its RSV vaccine candidate and researchers at the George Washington University are studying the vaccine’s safety and ability to trigger an immune response in two groups of people at risk for severe illness caused by respiratory syncytial virus or RSV.